Use of recombinase activation gene-2 deficient mice to ascertain the role of cellular and humoral immune responses in the development of chronic rejection

Journal of Heart and Lung Transplantation

Volumn 21, Issue 7, 2002, Pages 738-750

  Sun, Hong ^a   Woodward, Jennifer E ^a   Subbotin, Vladimir M ^a,b   Kuddus, Ruhul ^a   Logar, Alison J ^a   Schaefer, Adam T ^a   Aitouche, Abdelouahab ^a,c   Rao, Abdul S ^a,d  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b Mirus Bio Corporation   (United States)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^d DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIBODY; COMPLEMENT; CYTOKINE; RECOMBINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA GRAFT; ARTERY INTIMA PROLIFERATION; ARTICLE; B LYMPHOCYTE; BIOLOGICAL MODEL; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXICITY; DONOR; ENZYME ACTIVATION; GENE EXPRESSION; GRAFT REJECTION; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; MALE; MORPHOLOGY; MOUSE; MOUSE STRAIN; NONHUMAN; PATHOGENESIS; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE; TH1 CELL; TH2 CELL; WILD TYPE;

ANIMALS; ANTIBODY FORMATION; AORTA; B-LYMPHOCYTES; CHRONIC DISEASE; DNA-BINDING PROTEINS; GRAFT REJECTION; IMMUNITY, CELLULAR; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MODELS, ANIMAL; MUTATION; T-LYMPHOCYTES; TISSUE DONORS; TRANSFORMING GROWTH FACTOR BETA; TRANSPLANTATION, HOMOLOGOUS;

EID: 0036288504     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-2498(02)00393-5     Document Type: Article

References (33)

1. Risk factors for chronic rejection: A clinical perspective
2. Pathophysiology of chronic rejection
3. Immunobiology and pathology of chronic rejection
4. Chronic allograft failure: The clinical problem
5. Insights into acute and chronic rejection
6. Chronic rejection: Potential new sites of therapy
7. Improved surgical technique for the establishment of a murine model of aortic transplantation
8. Immunologic basis of transplant-associated arteriosclerosis
9. Coronary atherosclerosis in transplanted mouse hearts. II. Importance of humoral immunity
10. Abrogation of chronic rejection in a murine model of aortic allotransplantation by prior induction of donor-specific tolerance
11. Prevention of chronic rejection in mouse aortic allografts by combined treatment with CTLA4-Ig and anti-CD40 ligand monoclonal antibody
12. Lew-to-F344 carotid artery allografts: Analysis of a rat model of posttransplant vascular injury involving cell-mediated and humoral responses
13. Intimal thickening develops without humoral immunity in a mouse aortic allograft model of chronic vascular rejection
14. gld (CD95L) mutant recipients: The role of alloantibodies in the development of chronic rejection
15. Blockade of T-cell costimulation prevents development of experimental chronic renal allograft rejection
16. Rag-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement
17. Engraftment and humoral immunity in SCID and RAG-2-deficient mice transplanted with human peripheral blood lymphocytes
18. Rag-1-deficient mice have no mature B and T lymphocytes
19. Function and control of recombination-activating gene activity
20. RAG-1 and RAG-2, adjacent genes that synergistically activate V(D)J recombination
21. Restoration of T cell development in RAG-2-deficient mice by functional TCR transgenes
22. Analysis of gene function in lymphocytes by RAG-2-deficient blastocyst complementation
23. Regulation of anti-DNA B cells in recombination-activating gene-deficient mice
24. Pre-TCR signaling components trigger transcriptional activation of a rearranged TCRα gene locus and silencing of the pre-TCRα locus: Implications for intrathymic differentiation
25. α-smooth muscle actin, a differentiation marker of smooth muscle cells, is present in microfilamentous bundles of pericytes
26. A monoclonal antibody against a smooth muscle actin: A new probe for smooth muscle differentiation
27. A comparison of proliferating cell nuclear antigen (PNCA) immunostaining, nucleolar organizer region (AgNOR) staining, and histological grading in gastrointestinal stromal tumors
28. Assessment of human tumor proliferation using bromodeoxyuridine-current status
29. Presentation of MHC-disparate donor antigens predominantly by the indirect pathway results in the development of post-transplant vasculopathy: Salutary effects of perioperative co-stimulatory blockade
30. Blockade of the CD28/B7 and CD40/CD40L costimulatory pathways does not ameliorate chronic rejection development in a mouse aortic model of direct antigen presentation
31. -/- and SCID thymocytes on two genetic backgrounds: Developmental choices and cell death mechanisms before TCR gene rearrangement
32. Ig heavy chain class switching in rag-deficient mice
33. Endothelin in organ transplantation